Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.12 (
PKG
)
2,515
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Splicing factor 1
(
SF1
) functions at early stages of pre-mRNA splicing and contributes to splice site recognition by interacting with the essential splicing factor U2AF65 and binding to the intron branch site. We have identified an 80 kDa substrate of
cGMP-dependent protein kinase
-I (
PKG
-I) isolated from rat brain, which is identical to
SF1
.
PKG
phosphorylates
SF1
at Ser20, which inhibits the
SF1
-U2AF65 interaction leading to a block of pre-spliceosome assembly. Mutation of Ser20 to Ala or Thr also inhibits the interaction with U2AF65, indicating that Ser20 is essential for binding.
SF1
is phosphorylated in vitro by
PKG
, but not by cAMP-dependent protein kinase A (PKA). Phosphorylation of
SF1
also occurs in cultured neuronal cells and is increased on Ser20 in response to a cGMP analogue. These results suggest a new role for
PKG
in mammalian pre-mRNA splicing by regulating in a phosphorylation-dependent manner the association of
SF1
with U2AF65 and spliceosome assembly.
...
PMID:Phosphorylation of splicing factor SF1 on Ser20 by cGMP-dependent protein kinase regulates spliceosome assembly. 1044 20